Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
2.110
-0.060 (-2.76%)
At close: May 9, 2025, 4:00 PM
2.120
+0.010 (0.47%)
After-hours: May 9, 2025, 5:52 PM EDT
Heron Therapeutics Market Cap
Heron Therapeutics has a market cap or net worth of $321.91 million as of May 9, 2025. Its market cap has decreased by -23.52% in one year.
Market Cap
321.91M
Enterprise Value
448.49M
1-Year Change
-23.52%
Ranking
Category
Stock Price
$2.11
Market Cap Chart
Since December 1, 1998, Heron Therapeutics's market cap has increased from $127.40M to $321.91M, an increase of 152.68%. That is a compound annual growth rate of 3.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2025 | 331.10M | 42.29% |
| Dec 31, 2024 | 232.70M | -8.78% |
| Dec 29, 2023 | 255.10M | -14.17% |
| Dec 30, 2022 | 297.20M | -68.07% |
| Dec 31, 2021 | 930.70M | -51.60% |
| Dec 31, 2020 | 1.92B | -9.13% |
| Dec 31, 2019 | 2.12B | 4.57% |
| Dec 31, 2018 | 2.02B | 105.15% |
| Dec 29, 2017 | 986.50M | 92.15% |
| Dec 30, 2016 | 513.40M | -46.54% |
| Dec 31, 2015 | 960.40M | 227.11% |
| Dec 31, 2014 | 293.60M | 110.32% |
| Dec 31, 2013 | 139.60M | -15.24% |
| Dec 31, 2012 | 164.70M | 258.04% |
| Dec 30, 2011 | 46.00M | 154.14% |
| Dec 31, 2010 | 18.10M | -63.51% |
| Dec 31, 2009 | 49.60M | 281.54% |
| Dec 31, 2008 | 13.00M | -73.25% |
| Dec 31, 2007 | 48.60M | 39.66% |
| Dec 29, 2006 | 34.80M | -10.08% |
| Dec 30, 2005 | 38.70M | -6.30% |
| Dec 31, 2004 | 41.30M | -18.22% |
| Dec 31, 2003 | 50.50M | 146.34% |
| Dec 31, 2002 | 20.50M | -63.91% |
| Dec 31, 2001 | 56.80M | 18.33% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 674.60B |
| Johnson & Johnson | 374.53B |
| UnitedHealth Group | 349.75B |
| AbbVie | 328.29B |
| Novo Nordisk | 287.72B |
| Abbott Laboratories | 233.14B |
| Novartis AG | 215.89B |
| AstraZeneca | 208.98B |